Literature DB >> 1938322

A heart health assessment programme in general practice in County Kilkenny, Ireland.

E Shelley1, J Drynan, R Conroy, J Cuddihy, B Lee, P Magnier.   

Abstract

The Kilkenny Faculty of the Irish College of General Practitioners and the Kilkenny Health Project have established a Health Assessment Programme (HAP) to standardise the examination and recording of coronary heart disease (CHD) risk factors in general practice. Criteria were agreed for classification and coding of demographic data, relevant medical history and risk behaviours. Height, weight and blood pressure are measured and venous blood sample is taken for total cholesterol estimation. The assessment is followed by appropriate counselling. The HAP was first targetted at men and women aged 40 to 49 years. During the first 16 months of the programme, 2102 assessments were carried out by 41 general practitioners, which represents 29% of the target group. Those taking part had a lower social class distribution when compared with participants in the KHP baseline survey in 1985. There were no significant differences between the two groups in smoking prevalence or in the distribution of body mass index. Median cholesterol was 5% lower in the HAP group than at the baseline survey. 16% of the HAP clients had diastolic blood pressures of 90 mm Hg or more. The HAP has demonstrated that it is feasible to measure CHD risk factors in a variety of general practice settings. The format facilitates a preventive orientation and has proved acceptable to patients.

Entities:  

Mesh:

Year:  1991        PMID: 1938322     DOI: 10.1007/bf02950442

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  12 in total

1.  Risk assessment: its role in the prevention of coronary heart disease: recommendations of the scientific and medical advisory committee of the Coronary Prevention Group.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

2.  Blood cholesterol: is population screening warranted in the UK?

Authors:  W C Smith; M B Kenicer; A M Davis; A E Evans; J Yarnell
Journal:  Lancet       Date:  1989-02-18       Impact factor: 79.321

Review 3.  Making cervical screening work.

Authors:  A Smith; A Elkind; A Eardley
Journal:  BMJ       Date:  1989-06-24

4.  Identification and treatment of risk factors for coronary heart disease in general practice: a possible screening model.

Authors:  A Jones; D H Davies; J R Dove; M A Collinson; P M Brown
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-18

5.  Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.

Authors:  J Shepherd; D J Betteridge; P Durrington; M Laker; B Lewis; J Mann; J P Miller; J P Reckless; G R Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

6.  Would primary health care workers give appropriate dietary advice after cholesterol screening?

Authors:  J Francis; M Roche; D Mant; L Jones; E Fullard
Journal:  BMJ       Date:  1989-06-17

7.  Coronary heart disease: prevention and risk factors.

Authors:  G Fowler; E Fullard
Journal:  Practitioner       Date:  1989-03-22

8.  How-often-that-high graphs of serum cholesterol. Findings from the Scottish Heart Health and Scottish MONICA studies.

Authors:  H Tunstall-Pedoe; W C Smith; R Tavendale
Journal:  Lancet       Date:  1989-03-11       Impact factor: 79.321

9.  Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.

Authors: 
Journal:  Eur Heart J       Date:  1987-01       Impact factor: 29.983

10.  Trends in cardiovascular disease mortality in industrialized countries since 1950.

Authors:  K Uemura; Z Pisa
Journal:  World Health Stat Q       Date:  1988
View more
  1 in total

1.  The Kilkenny Health Project: a community research and demonstration cardiovascular health programme.

Authors:  E Shelley; L Daly; I Graham; A Beirne; R Conroy; M Gibney; N Hickey; D Kilcoyne; B Lee; T O'Dwyer
Journal:  Ir J Med Sci       Date:  1991-01       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.